hotspot -WSS

hotspot

author：focus 2025-09-28 21:11:19 - browse：1139

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： 6 surprising facts about sugar

WSS

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Using force crossed my mind when examining a defiant young patient

Testing GLP

Pfizer is about to make a big push in cancer. Will investors listen?

Adam's Take: Intra

Diabetes management: Digital health tools fall short, study says

Wikipedia

hotspot

entertainment

Peter Hotez and the public health issue of online harassment

With Wegovy coverage, Medicare patients may face high costs

Hepatitis C has a cure — but many Americans still lack access to it

Erich Jarvis studies song birds to learn about human stuttering

Duchenne breakthrough therapy leaves behind pioneering families

Mirador, a new biotech startup, launches with $400 million

George Santos makes 1st court appearance after pleading not guilty to 13 counts

'Patient friction coefficient' can gauge a clinical trial's patient burden

The cancer drug shortage isn’t new — and neither are the solutions

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Wikipedia

Redefining sustainability for the pharmaceutical industry

'Vaccine

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Virtual repurposing can help discover new uses for existing drugs

Surgeons perform first xenotransplant using CRISPR'd pig kidney

CRISPR technology availability, affordability needs to be expanded

hotspot

explore

focus

leisure time